Featured article

IONTAS announces Mammalian Display licensing agreement with Bristol Myers Squibb

IONTAS’ proprietary mammalian display technology enables large libraries of full-length antibodies to be expressed on the surface of mammalian cells, in a way that allows selection for optimal binding properties and optimal biophysical properties.